16th October 2021 | Pharma Updates

Wockhardt will make 500 mn mystery vaccines

The drugmaker will supply the vaccine to the principal innovator and they will launch the vaccine in India.

‘Industry-academia partnership in biotherapeutics research to address unmet demands’

Drug and biopharma companies are entering into partnerships with good universities for biotherapeutics research.

Another ITAT bench to govern drugmakers freebies

A two-member of the ITAT bench has directed larger bench should check whether the expenses on freebies to medical doctors
incurred by drugmakers should be allowed as a deduction.

Bulk drugs industry may see flurry of deals in future

Indian drug companies may see an unprecedented deals spree in next three months, with around six transactions worth over USD 1 bn in final negotiations, people aware of the matter said.

Cipla achieves spot in Forbes’ “World’s Best Employers 2021” list

Cipla is the only Indian drugmaker to secure a spot in the Forbes “World’s Best Employers 2021” list among the top global employers across 58 nations.

DRL launches Carmustine for injection, USP

DRL’s carmustine for injection, USP is a lyophilized powder as a packet which includes a vial containing 100-milligram carmustine USP and a vial containing 3- millilitre sterile diluent.

India again start Covid vaccine export

One million shots of Covaxin were transported to Iran last week.